Nephros (NEPH) Profit After Tax Growth (3y) (2013 - 2026)
Nephros (NEPH) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 21.52% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -27.66% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 2.79% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 19.70% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -0.24% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -64.60% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -67.40% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 8.70% |
| 10 | Nephros | 36.20 Mn | 32.18 Mn | 2.99 Mn | 34.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.95% |
| Dec 31, 2025 | -68.49% |
| Sep 30, 2025 | 28.20% |
| Jun 30, 2025 | 30.23% |
| Mar 31, 2025 | 31.69% |
| Dec 31, 2024 | 34.04% |
| Sep 30, 2024 | 29.21% |
| Jun 30, 2024 | 36.45% |
| Mar 31, 2024 | 31.98% |
| Dec 31, 2023 | 4.84% |
| Sep 30, 2023 | 43.55% |
| Jun 30, 2023 | 36.07% |
| Mar 31, 2023 | 34.68% |
| Dec 31, 2022 | 150.70% |
| Sep 30, 2022 | -57.26% |
| Jun 30, 2022 | -6.47% |
| Mar 31, 2022 | -13.40% |
| Dec 31, 2021 | -9.01% |
| Sep 30, 2021 | -28.46% |
| Jun 30, 2021 | -18.19% |